NSE: AKUMS - Akums Drugs and Pharmaceutical
Yield per half year: -40.06%
Dividend yield: 0.00%
Reporting Akums Drugs and Pharmaceutical
Efficiency
IFRS
Annual
| 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | ||||
| Ebit margin, % | 0 | 0 | ||||
| Рентаб EBITDA, % | 0 | 0 | ||||
| Operation Margin, % | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
